SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
443.00    10.00 (2.31%)
Bid:
440.00
Ask:
443.00
Spread: 3.00 (0.682%)
Market Cap: £218.72m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

Interim Management Statement

8 Oct 2015 07:00

RNS Number : 5957B
City of London Investment Group PLC
08 October 2015
 



CITY OF LONDON INVESTMENT GROUP PLC

("City of London", "the Company" or "the Group")

Trading Update - 1st Quarter Funds under management (FuM)

City of London (LSE: CLIG), a leading emerging markets asset management group, announces that as at 30th September 2015, FuM were US$3.6 billion (£2.4 billion). This compares with US$4.2 billion (£2.7 billion) at the Company's year-end on 30th June 2015. In US dollar terms, this represents a fall of c14% compared to the MSCI Emerging Markets Index (US dollar based), which fell by c18% over the same period.

Despite the recent market volatility, the Board is encouraged by the diversity in the current pipeline of potential mandates, with c$750 million spread across EM, Frontier, Developed and Tactical Asset Allocation asset classes. As a result the Company is hopeful that at least a net $250 million of additional FuM should be achievable over the next 6-9 months.

Monthly updates of FuM are available on our website -www.citlon.co.uk.

Operations

The Group's income currently accrues at a weighted average rate of approximately 85 basis points, net of third party commissions. "Fixed" costs for the quarter were a little over £0.8 million per month, and accordingly the current run-rate for operating profit, before profit-share at 30%, is approximately £0.8 million per month based upon current FuM and a US$/£ exchange rate of US$1.52 to £1. The Group estimates that the post-tax profit for the first three months of the year will be approximately £1.2 million, after an unrealised loss on seed investments of £0.2 million.

Appropriate steps are being taken to reduce the firm's overhead.

Having provided shareholders with both a template and assumptions via which they can determine their own estimate of CLIG's profitability, shareholders can accordingly adjust their estimates based on the recent fall in markets.

Dividends

The final dividend of 16 pence per share, subject to approval at the AGM on 19th October, will be paid on 30th October 2015, bringing the total dividend for the financial year 2014-15 to 24 pence.

Investor afternoon

Shareholders and other interested parties are invited to attend our investor afternoon starting at 3pm on 19th October at the offices of Canaccord Genuity Limited, 88 Wood Street, London EC2V 7QR.

Presentations will include: Managing the P&L through a difficult market environment, Core values, EM CEF strategy, EM-What could go right?, Diversification CEF strategies and US marketing initiatives.

If you would like to attend then please email investorrelations@citlon.co.uk as spaces are limited.

 

For further information please visit www.citlon.co.uk or contact:

Barry Olliff (CEO)

City of London Investment Group PLC

Tel: 001 215 313 3774

 

Roger Lambert

Canaccord Genuity Limited

Financial Adviser & Broker

Tel: +44 (0)20 7523 8000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDMMGGVNKGKZM
Date   Source Headline
22nd Sep 201711:08 amRNSHolding(s) in Company
18th Sep 20177:00 amRNSFinal Results
8th Sep 20177:53 amRNSDirector/PDMR Shareholding
31st Aug 20174:00 pmRNSOpen letter to the board of icapital.biz Berhad
20th Jul 20176:22 pmRNSHolding(s) in Company
19th Jul 20177:00 amRNSTrading Update
13th Jul 20176:15 pmRNSHolding(s) in Company
13th Jul 20177:00 amRNSChange of announcement date
13th Jun 20174:26 pmRNSBoard Changes
26th May 20173:49 pmRNSDirector/PDMR Shareholding
25th May 20172:12 pmRNSDirector/PDMR Shareholding
22nd May 201712:56 pmRNSHolding(s) in Company
8th May 20176:03 pmRNSShare Buyback and Total Voting Rights
26th Apr 20173:37 pmRNSHolding(s) in Company
18th Apr 20171:56 pmRNSDirector/PDMR Shareholding
11th Apr 20177:00 amRNSTrading Update
3rd Apr 201712:42 pmRNSHolding(s) in Company
24th Mar 20172:28 pmRNSHolding(s) in Company
21st Mar 20175:20 pmRNSHolding(s) in Company
22nd Feb 20171:40 pmRNSDirector/PDMR Shareholding
22nd Feb 20171:37 pmRNSDirector/PDMR Shareholding
20th Feb 20177:46 amRNSHALF YEAR RESULTS TO 31ST DECEMBER 2016
24th Jan 20173:24 pmRNSHardman Research:Q2 statement robust profitability
17th Jan 20177:00 amRNSFunds Under Management - Trading Update
24th Nov 20163:42 pmRNSDirector/PDMR Shareholding
19th Oct 201611:15 amRNSAGM resolutions
17th Oct 20165:49 pmRNSResult of AGM
13th Oct 20163:05 pmRNSDirector/PDMR Shareholding
11th Oct 20165:13 pmRNSHolding(s) in Company
11th Oct 20162:51 pmRNSDirector/PDMR Shareholding
10th Oct 20167:46 amRNSAGM Trading Update - 1st Qtr Funds under Mgmt
15th Sep 20169:46 amRNSLetter to icapital.biz Berhad
14th Sep 20169:32 amRNSHardman Report: Exchange rate moves give big boost
12th Sep 20167:00 amRNSFINAL RESULTS FOR THE YEAR TO 30TH JUNE 2016
18th Jul 20167:00 amRNSTrading Update
1st Jul 20167:00 amRNSBlock listing cancellation & block listing return
30th Jun 20164:40 pmRNSSecond Price Monitoring Extn
30th Jun 20164:35 pmRNSPrice Monitoring Extension
23rd Jun 20165:55 pmRNSDirector/PDMR Shareholding
14th Apr 201612:38 pmRNSHardman & Co Issues Research Report
22nd Feb 201611:18 amRNSDirector/PDMR Shareholding
15th Feb 20167:00 amRNSHalf Yearly Report
5th Feb 20164:40 pmRNSSecond Price Monitoring Extn
5th Feb 20164:35 pmRNSPrice Monitoring Extension
29th Jan 20164:41 pmRNSSecond Price Monitoring Extn
29th Jan 20164:35 pmRNSPrice Monitoring Extension
27th Jan 20164:40 pmRNSSecond Price Monitoring Extn
27th Jan 20164:35 pmRNSPrice Monitoring Extension
13th Jan 20169:57 amRNSHardman Issues Research Report
12th Jan 20167:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.